A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
Times Cited: 850




List of shared articles



Times cited

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Melanie Care, Jeanna McCuaig, Blaise Clarke, Sylvie Grenier, Raymond H Kim, Marjan Rouzbahman, Natalie Stickle, Marcus Bernardini, Tracy L Stockley. Mol Oncol 2021
3

Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
Lorenzo Ceppi, Tommaso Grassi, Francesca Galli, Alessandro Buda, Giovanni Aletti, Andrea Alberto Lissoni, Marco Adorni, Annalisa Garbi, Nicoletta Colombo, Cristina Bonazzi,[...]. Gynecol Oncol 2021
0

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Renee Cowan, Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin C Zhou, Alexia Iasonos, Robert A Soslow, Angela G Arnold, Magan Trottier, Amanda Catchings,[...]. Gynecol Oncol 2021
0

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Gang Ji, Qianlan Yao, Longlong Bao, Jing Zhang, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Rui Bi, Xiaoyan Zhou. Ann Transl Med 2021
0

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0

Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.
Selin Oncul, Paola Amero, Cristian Rodriguez-Aguayo, George A Calin, Anil K Sood, Gabriel Lopez-Berestein. RNA Biol 2020
5

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1